Ovarian Cancer Treatment at CritiCare Asia Hospitals, Juhu
The ovaries are small, almond-shaped organs, but they're made up of three distinct cell types - epithelial, germ, and stromal - and each can give rise to a different kind of tumour. Ovarian cancer refers to any cancerous growth arising in this tissue. It's the second most common gynaecologic cancer, and one where early detection remains genuinely difficult, not for lack of awareness, but because of how the disease tends to present. Consult highly experienced and trained ovarian cancer specialists at CritiCare Asia Hospitals, Juhu for ovarian cancer treatment.
Types of Ovarian Cancer
- Epithelial tumours
arising from the outer lining of the ovary; account for roughly 9 in 10 ovarian cancer cases - Germ cell tumours
originate in the egg-producing cells, more often seen in younger women - Stromal tumours
develop in the hormone-producing connective tissue of the ovary, comparatively rare
Epithelial ovarian cancer dominates clinical practice by sheer volume, which is why most diagnostic and treatment protocols are built around it.
Why Ovarian Cancer Symptoms are Often Missed
Ovarian cancer has earned an unfortunate reputation as a "silent" disease, though that's not entirely accurate - it's more that the symptoms speak in a language easily mistaken for something else. Bloating, pelvic discomfort, feeling full after a few bites, needing to urinate more frequently: each of these has dozens of ordinary, benign explanations. A woman experiencing them is far more likely to suspect digestion, stress, or diet before she considers her ovaries. That's precisely the problem. These symptoms only raise real concern when they're new, persistent, and occur together - happening most days for several weeks rather than passing in a day or two. Recognizing that pattern, rather than any single symptom in isolation, is what prompts timely evaluation. Consult the best oncologists in Mumbai at CritiCare Asia Hospitals for further evaluation and care.
Risk Factors of Ovarian Cancer
- Family history
close relatives with ovarian or breast cancer raise personal risk meaningfully - BRCA1/BRCA2 mutations
inherited mutations substantially increase lifetime risk - Age
most cases occur in women past 65, though younger women aren't exempt - Endometriosis
associated with a higher likelihood of certain ovarian cancer subtypes - Nulliparity or infertility
women who haven't carried a pregnancy, or who've undergone fertility treatment, carry somewhat elevated risk - Hormone replacement therapy
long-term use is linked to a modest increase in risk, which appears to normalize after stopping - Obesity
associated with higher risk across several cancer types, ovarian cancer included
Having one or more of these factors doesn't mean cancer is inevitable - it means a conversation with a gynaecologic oncologist about personal risk is worthwhile, particularly for women with a strong family history.
How is Ovarian Cancer Screened?
Unlike cervical cancer, there is no reliable population-wide screening test for ovarian cancer, and it's worth saying that plainly rather than implying otherwise. CA-125 blood testing and transvaginal ultrasound are sometimes used, particularly for women at elevated genetic risk. Still, neither is accurate enough to screen the general population effectively - CA-125 can rise due to entirely benign conditions, and early tumours don't always show up clearly on ultrasound. For women with BRCA mutations or a strong family history, a genetic counsellor can help decide whether closer surveillance or risk-reducing strategies make sense on an individual basis. Consult oncologists at the best cancer hospital in Juhu, CritiCare Asia Hospitals, for assistance with screening for ovarian cancer.
How is Ovarian Cancer Diagnosed?
Diagnosis typically combines several tools rather than relying on one. A pelvic exam and transvaginal ultrasound are usually the starting point, followed by CA-125 testing and cross-sectional imaging such as CT or MRI to assess the extent of disease. A definitive diagnosis, though, generally requires surgical biopsy - and in ovarian cancer, diagnosis and initial treatment are frequently combined into a single surgical procedure rather than staged separately.
Staging of Ovarian Cancer
Ovarian cancer is staged using the FIGO system, which classifies disease from Stage I (confined to one or both ovaries) through Stage IV (spread to distant organs beyond the abdomen). Each stage is further subdivided based on precisely how far the cancer has extended - whether it remains within the pelvis, has reached the abdominal lining, or has moved to lymph nodes or distant sites. Staging is usually confirmed during surgery itself, which is part of why surgical exploration plays such a central role early in treatment.
Treatment Options for Ovarian Cancer
- Cytoreductive (debulking) surgery
removes as much visible tumour as possible; often combined with staging and diagnosis in the same procedure - Chemotherapy
typically follows surgery to eliminate residual cancer cells, sometimes delivered intraperitoneally in addition to systemic administration - Fertility-preserving surgery
an option for select younger patients with early-stage disease confined to one ovary - Radiation therapy
used infrequently, generally reserved for recurrence rather than primary treatment
Experts at CritiCare Asia Hospitals recommend ovarian cancer surgery in Mumbai only when required, with minimally invasive techniques considered where disease looks localized.
Ovarian Cancer Treatment at CritiCare Asia Hospitals, Juhu
At CritiCare Asia Hospitals, we offer comprehensive ovarian cancer treatment in Juhu, Mumbai that starts with accurate staging, since treatment strategy shifts considerably depending on how far disease has spread at diagnosis. The gynaecologic oncology team evaluates each case individually - weighing surgical approach, chemotherapy sequencing, and fertility considerations where relevant - rather than applying a single fixed protocol. If you're experiencing persistent bloating, pelvic discomfort, or other symptoms that haven't resolved, speak with our oncology team for evaluation.